Integrin beta 3/CD61 Antibody (BV4)
Novus Biologicals, part of Bio-Techne | Catalog # NB600-1342
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat, Bovine
Cited:
Mouse, Rat
Applications
Validated:
Functional, Immunoassay, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry-Paraffin, Immunoprecipitation, Western Blot
Cited:
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # BV4
Concentration
0.1 mg/ml
Product Specifications
Immunogen
Mouse Integrin alpha V beta 3
Reactivity Notes
Rat reactivity reported in scientific literature (PMID: 23857293). Mouse reactivity reported in scientific literature (PMID: 28050799).
Specificity
The monoclonal antibody BV4 recognizes human beta3 integrin subunit present in Platelet glycoprotein GPIIb-IIIa (integrin alphaIIb/beta3, CD41/CD61) and in the vitronectin receptor (integrin alphaV/beta3, CD51/CD61).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Integrin beta 3/CD61 Antibody (BV4)
Application
Recommended Usage
Immunohistochemistry
1:50
Immunohistochemistry-Frozen
1:50
Immunohistochemistry-Paraffin
1:50
Immunoprecipitation
1:10-1:500
Western Blot
1:50
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS containing 0.1% BSA
Preservative
0.02% Sodium Azide
Concentration
0.1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C.
Background: Integrin beta 3/CD61
Alternate Names
CD61, GP3A, GPIIIA, INGRB3, ITGB3
Entrez Gene IDs
3690 (Human)
Gene Symbol
ITGB3
UniProt
Additional Integrin beta 3/CD61 Products
Product Documents for Integrin beta 3/CD61 Antibody (BV4)
Product Specific Notices for Integrin beta 3/CD61 Antibody (BV4)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...